Global News

U.K. announces $21M investment in stratified medicine

Friday, January 30, 2015 12:29 PM

Minister for Life Sciences George Freeman has announced a further $20.6 million investment in stratified medicine collaborations funded by the Medical Research Council (MRC). Four new awards bring the total of stratified medicine consortia funded by the MRC to 13, with investments totaling over $21 million—part of the government’s $195.4 million commitment to stratified medicine set out in the U.K. life sciences strategy.

More... »


AstraZeneca collaborates to use CRISPR technology

Friday, January 30, 2015 12:27 PM

AstraZeneca has announced four research collaborations aimed at harnessing the power of CRISPR, a pioneering genome-editing technique, across its entire discovery platform in the company’s key therapeutic areas. The four research collaborations are with the Wellcome Trust Sanger Institute, Cambridge, U.K.; the Innovative Genomics Initiative, California; Thermo Fisher Scientific, Waltham, Mass.; and the Broad Institute/Whitehead Institute, Cambridge, Mass. The technology will allow AZ to identify and validate new drug targets in preclinical models that closely resemble human disease.

More... »


Astellas Pharma, Immunomic Therapeutics collaborate

Friday, January 30, 2015 12:25 PM

Immunomic Therapeutics, a company developing next-generation vaccines based on the LAMP-vax platform headquartered in Hershey, Pa., and Astellas Pharma of Tokyo have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen. The companies expect to initiate a phase I trial of JRC2-LAMP-vax in Japan as soon as it is ready.

More... »

Investigator training efficiencies highlighted in new CTTI GCP recommendations

Friday, January 30, 2015 12:14 PM

The Clinical Trials Transformation Initiative (CTTI), based in Durham, N.C., has announced recommendations to streamline Good Clinical Practice (GCP) training of investigators who participate in clinical trials. GCP is an international standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials.

More... »

Inovio Pharmaceuticals appoints Mark Gelder vice president, clinical development

Thursday, January 29, 2015 01:09 PM

Inovio Pharmaceuticals has appointed Mark Stephen Gelder, M.D., as vice president, clinical development. Gelder will be responsible for planning and executing Inovio's clinical development strategy for its immunotherapies against human papillomavirus (HPV)-caused cervical cancer and dysplasia. He will report to Dr. Mark Bagarazzi, Inovio's chief medical officer.

More... »

Amerita acquires Infusionrx

Thursday, January 29, 2015 12:40 PM

Amerita, an Irvine, Calif.-based, wholly owned subsidiary of institutional pharmacy services company PharMerica, has completed the acquisition of Coastal Pharmaceutical Services company InfusionRx, based in Oxnard, Calif. Financial terms of the transaction have not been disclosed.

More... »

Regulatory update on GSK-Novartis three-part transaction

Thursday, January 29, 2015 12:25 PM

GlaxoSmithKline has received clearance from the European Commission (E.C.) of its proposed three-part transaction with Novartis, which includes the acquisition of Novartis’s vaccines business (excluding influenza vaccines), the creation of a consumer healthcare joint venture between GSK and Novartis and the divestment to Novartis of GSK’s marketed oncology portfolio, related R&D activities and rights to two pipeline AKT inhibitors.

More... »

Icon creates new global innovation hub in Ireland to advance clinical development

Thursday, January 29, 2015 12:22 PM

Global CRO Icon has launched a new global innovation hub that will create 200 new jobs in Ireland.

More... »

Chiltern earns five spots in PharmaTimes Clinical Researcher of the Year finals

Thursday, January 29, 2015 10:47 AM

Chiltern, a global CRO, has earned five nominations in the PharmaTimes Clinical Researcher of the Year finals for the project manager, clinical research associate (CRA) and new CRA categories.

More... »

Synergy Research Group speeds ramp-up time for clinical trials

Wednesday, January 28, 2015 12:06 PM

Synergy Research Group, a CRO based in Moscow, Russia, is addressing one of the most common roadblocks to clinical trial ramp-up by taking sales and business development out of the proposal and/or bid cycle. This is another step in Synergy’s commitment to offer quality, speed and lower cost to every sponsor.

More... »

`
CenterWatch Data Library
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs